Francesco Botre

Prof. Dr. Francesco Botre

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2010 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
ACAmy B Cadwallader
Amy B Cadwallader
XTXavier de la Torre
Xavier de la Torre
ATAlessandra Tieri
Alessandra Tieri
FBFrancesco Botre
Francesco Botre



27 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FAFatima Al-Khelaifi
Fatima Al-Khelaifi
IDIlhame Diboun
Ilhame Diboun
FDFrancesco Donati
Francesco Donati
FBFrancesco Botre
Francesco Botre
DADavid Abraham
David Abraham
Mohamed ElrayessMohamed Elrayess
Mohamed Elrayess
Genetic research of elite athletic performance has been hindered by the complex phenotype and the relatively small effect size of the identified genetic variants. The aims of this study were to identify genetic predisposition to elite athletic performance by investigating genetically-influenced metabolites that discriminate elite athletes from non-elite athletes and to identify those associated with endurance sports. By conducting a genome wide association study with high-resolution metabolomics profiling in 490 elite athletes, common variant metabolic quantitative trait loci (mQTLs) were identified and compared with previously identified mQTLs in non-elite athletes. Among the identified mQTLs, those associated with endurance metabolites were determined. Two novel genetic loci in FOLH1 and VNN1 are reported in association with N-acetyl-aspartyl-glutamate and Linoleoyl ethanolamide, respectively. When focusing on endurance metabolites, one novel mQTL linking androstenediol (3alpha, 17alpha) monosulfate and SULT2A1 was identified. Potential interactions between the novel identified mQTLs and exercise are highlighted. This is the first report of common variant mQTLs linked to elite athletic performance and endurance sports with potential applications in biomarker discovery in elite athletic candidates, non-conventional anti-doping analytical approaches and therapeutic strategies.

9 February 2008 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
MMMonica Mazzarino
Monica Mazzarino
STStefania Turi
Stefania Turi
FBFrancesco Botre
Francesco Botre

21 October 2020 in Toxics
Verified
Journal Article
Open access
PDF file
Donatella PaoliDonatella Paoli
Donatella Paoli
FPFrancesco Pallotti
Francesco Pallotti
ADAnna Pia Dima
Anna Pia Dima
EAElena Albani
Elena Albani
CACarlo Alviggi
Carlo Alviggi
LSLucia De Santis
Lucia De Santis
Background: folliculogenesis is a strictly regulated process that may be affected by endocrine disrupting chemicals (EDCs) through sometimes not so clear molecular mechanisms. Methods: we conducted a multicentric observational study involving six fertility centers across Italy, prospectively recruiting 122 women attending a fertility treatment. Recruited women had age ≤42 years, and normal ovarian reserve. Blood and follicular fluid samples were taken for EDCs measurement using liquid chromatography tandem mass spectrometry and each woman completed an epidemiological questionnaire. Results: The main EDCs found were monobutyl phthalate (MBP) (median blood: 8.96 ng/mL, follicular fluid 6.43 ng/mL), monoethylhexyl phthalate (MEHP) (median blood: 9.16 ng/mL, follicular fluid 7.68 ng/mL) and bisphenol A (BPA) (median blood: 1.89 ng/mL, follicular fluid 1.86 ng/mL). We found that serum MBP concentration was significantly associated with the considered area (p < 0.001, adj. mean: 7.61 ng/mL, 14.40 ng/mL, 13.56 ng/mL; Area 1: Milan–Turin, Area 2: Rome–Naples; Area 3: Catania–Bari, respectively) but negatively with home plastic food packaging (p = 0.004). Follicular MBP was associated with irregular cycles (p = 0.019). No association was detected between EDCs and eating habits and other clinical and epidemiological features. Conclusions: This study represents the first Italian biomonitoring of plastic EDCs in follicular fluid, laying the basis for future prospective evaluation on oocyte quality before assisted reproduction techniques (ART).